Literature DB >> 3244418

CSF-endorphines in acute and chronic brain lesions.

E Hamel1.   

Abstract

In order to answer the question of an opioid influence on consciousness, a radio-immuno-assay (n = 852) of beta-endorphin and beta-LPH (beta-lipotropic hormone) in both ventricular CSF and blood plasma was carried out in 101 neurosurgical patients. The following results were obtained: I) beta-END and beta-LPH levels were found to be lower in the CSF than in blood plasma. II) beta-END and beta-LPH in the CSF was the same in both sexes. III) beta-END levels in the CSF decreased with age. IV) beta-END and beta-LPH levels showed a diurnal rhythm with a maximum in the late a. m. hours. V) beta-END levels in the ventricular CSF tend to decrease parallel to a drop in conciousness as well as with longlasting comatous states. VI) beta-END in ventricular CSF becomes higher with increasing systolic arterial blood pressure. VII) beta-END and beta-LPH levels in ventricular CSF are not correlated with the type of the disease, CSF pressure, body temperature or respiratory changes.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3244418     DOI: 10.1007/bf01794687

Source DB:  PubMed          Journal:  Neurosurg Rev        ISSN: 0344-5607            Impact factor:   3.042


  25 in total

1.  Isolation of an endogenous compound from the brain with pharmacological properties similar to morphine.

Authors:  J Hughes
Journal:  Brain Res       Date:  1975-05-02       Impact factor: 3.252

2.  The use of naloxone in the treatment of diazepam poisoning.

Authors:  E F Bell
Journal:  J Pediatr       Date:  1975-11       Impact factor: 4.406

3.  The role of the reticular formation in the coma of head injury.

Authors:  E L FOLTZ; R P SCHMIDT
Journal:  J Neurosurg       Date:  1956-03       Impact factor: 5.115

4.  Brain energy metabolism and catecholaminergic activity in hypoxia, hypercapnia and ischemia.

Authors:  B K Siesjö
Journal:  J Neural Transm Suppl       Date:  1978

5.  Hyper-endorphin syndrome in a child with necrotizing encephalomyelopathy.

Authors:  N J Brandt; L Terenius; B B Jacobsen; L Klinken; A Nordius; S Brandt; K Blegvad; M Yssing
Journal:  N Engl J Med       Date:  1980-10-16       Impact factor: 91.245

6.  Stereospecific binding of the potent narcotic analgesic (3H) Etorphine to rat-brain homogenate.

Authors:  E J Simon; J M Hiller; I Edelman
Journal:  Proc Natl Acad Sci U S A       Date:  1973-07       Impact factor: 11.205

7.  Naloxone administration to patients with acute stroke.

Authors:  J Jabaily; J N Davis
Journal:  Stroke       Date:  1984 Jan-Feb       Impact factor: 7.914

8.  Immunoreactive beta-endorphin in human cerebrospinal fluid.

Authors:  K Nakao; Y Nakai; S Oki; S Matsubara; T Konishi; H Nishitani; H Imura
Journal:  J Clin Endocrinol Metab       Date:  1980-02       Impact factor: 5.958

9.  beta-Endorphin immunoreactivity and acute behavioral distress in children with leukemia.

Authors:  E R Katz; B Sharp; J Kellerman; A R Marston; J M Hershman; S E Siegel
Journal:  J Nerv Ment Dis       Date:  1982-02       Impact factor: 2.254

10.  Diurnal fluctuations in methionine-enkephalin levels in the hypothalamus and preoptic area of the male rat: effects of pinealectomy.

Authors:  M S Kumar; C L Chen; D C Sharp; J M Liu; P S Kalra; S P Kalra
Journal:  Neuroendocrinology       Date:  1982       Impact factor: 4.914

View more
  2 in total

1.  Cerebrospinal fluid and plasma β-endorphin levels in children with cerebral malaria.

Authors:  Oluwatosin Eunice Olorunmoteni; Oluwagbemiga Oyewole Adeodu; Saheed B A Oseni; Efere M Obuotor
Journal:  Brain Behav       Date:  2017-03-17       Impact factor: 2.708

2.  Volume transmission of beta-endorphin via the cerebrospinal fluid; a review.

Authors:  Jan G Veening; Peter O Gerrits; Henk P Barendregt
Journal:  Fluids Barriers CNS       Date:  2012-08-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.